Kangzhong Medical had two block trades on March 30, with a total transaction amount of 5.0769 million yuan, including institutional purchases of 5.0769 million yuan. The premium rate was -10.00%.

robot
Abstract generation in progress

For stock trading, just look at Jinqilin’s analyst research reports—authoritative, professional, timely, comprehensive—helping you uncover potential theme opportunities!

On March 30, Kangzhong Medical rose 7.96%, closing at 61.99 yuan. There were 2 block trades, totaling 91,000 shares, with a transaction value of 5.0769 million yuan.

The first trade’s成交 price was 55.79 yuan,成交 volume 55.00 thousand shares,成交 value 3.0685 million yuan, with a premium rate of -10.00%. The buying party’s business department was designated for institutions, and the selling party’s business department was CITIC Securities Co., Ltd., Shanghai Branch.

The second trade’s成交 price was 55.79 yuan,成交 volume 36.00 thousand shares,成交 value 2.0084 million yuan, with a premium rate of -10.00%. The buying party’s business department was designated for institutions, and the selling party’s business department was CITIC Securities Co., Ltd., Shanghai Branch.

Further statistics show that within the past 3 months, this stock has had a total of 6 block trades, with a combined transaction value of 112 million yuan. Over the past 5 trading days, the stock has cumulatively risen 26.51%, and main fund flows totaled a net inflow of 28.874 million yuan.

Statement: The market involves risks; investment requires caution. This article is automatically published based on a third-party database and does not represent Sina Finance’s viewpoints. Any information appearing in this article is for reference only and does not constitute personal investment advice. If there are discrepancies, please refer to the actual announcements. If you have any questions, please contact biz@staff.sina.com.cn。

Massive information and precise interpretation—right on the Sina Finance app

责任编辑:小浪快报

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin